학술논문
TP53 status for prediction of sensitivity to taxane versus non-taxane neoadjuvant chemotherapy in breast cancer (EORTC 10994/BIG 1-00): a randomised phase 3 trial
Document Type
Artikel
Author
Source
The Lancet. Oncology. 12(6):527-539
Subject
Language
English
English
English
ISSN
1474-5488